Financials
Financial year 2026
DE RUYCK PHARMA from Deinze, company number BE0818535488, closed financial year 2026 with a result of € 47,788 after tax. For that financial year DE RUYCK PHARMA recorded a gross margin of € 195,621 and equity of € 353,696. Compared with financial year 2025, the result moved from € 48,219 to € 47,788. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 2, 2026.
€ 353,696
▲ 15% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 47,788
▼ 1% vs 2025
Profit after tax over the fiscal year.
€ 161,050
▲ 146% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 1,000 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
0.3
▲ 0.1 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 4,717
▼ 55% vs 2025
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 20,777
▼ 46% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 933,923
▼ 8% vs 2025
€ 119,918 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 266,850
▲ 97% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 1,502
▼ 80% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 249,852 | € 178,233 | € 199,257 | € 195,621 | ▼ 2% |
| Profit after taxes | € 55,070 | € 50,055 | € 48,219 | € 47,788 | ▼ 1% |
| Equity | € 250,144 | € 300,199 | € 306,908 | € 353,696 | ▲ 15% |
| Total debts | € 1,393,059 | € 1,300,650 | € 1,164,355 | € 1,204,211 | ▲ 3% |
| Cash | € 114,345 | € 82,605 | € 65,417 | € 161,050 | ▲ 146% |
| Land & buildings | € 1,122,000 | € 1,094,641 | € 1,047,817 | € 1,002,301 | ▼ 4% |
| Retained profit | € 231,544 | € 281,599 | € 288,308 | € 335,096 | ▲ 16% |
| Dividend | € 48,633 | € 0 | € 41,511 | € 1,000 | ▼ 98% |
| Bank debt | € 1,289,530 | € 1,117,220 | € 1,018,738 | € 933,923 | ▼ 8% |
| Balance sheet total | € 1,643,203 | € 1,600,849 | € 1,471,263 | € 1,557,907 | ▲ 6% |
| Employees (FTE) | 0.8 | - | 0.2 | 0.3 | ▲ 0.1 |
By gross margin, DE RUYCK PHARMA ranks 6th of 9 companies with main activity “Detailhandel in farmaceutische producten” in Deinze that publish figures (fiscal year 2026).
Key figures of DE RUYCK PHARMA, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about DE RUYCK PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DE RUYCK PHARMA?
What happened at DE RUYCK PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 47,788 (▼ 1% vs 2025). filed late Source: NBB ↗
- New establishment in Knokke-Heist. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Deinze. KBO
In short
From € 55,070 profit in 2023 to € 47,788 profit in 2026.
Paid € 84,585 in corporate taxes since 2023.
Best year ever: 2023, with € 55,070 profit.
Paid out € 91,144 in dividends to the owners in total.
Management
Behind DE RUYCK PHARMA are Lien Van Hauwermeiren and Bertolt De Ruyck.
Directors
According to the 2026 annual accounts
Lien Van Hauwermeiren
Director
Bertolt De Ruyck
Director
Establishments
Establishment units
Physical locations of this company
Aarseleweg 2
9800 Deinze
Van Bunnenlaan 29
8300 Knokke-Heist
Active since 20 September 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Deinze
Same main activity (Detailhandel in farmaceutische producten), 12 active companies in Deinze, largest first.
€ 389,512 gross margin · 2025
€ 347,612 gross margin · 2025
€ 322,026 gross margin · 2025
€ 228,945 gross margin · 2025
€ 215,257 gross margin · 2025
€ 148,206 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DE RUYCK Bertolt Hubert(oprichter) 100%
Details
- Company number
- 0818.535.488
- VAT number
- BE 0818.535.488
- Registered office
- Aarseleweg 2, 9800 Deinze
- Names & denominations
- DE RUYCK PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 September 2009
- Peppol
- Active · Active since 13 Feb 2024
- Activities · NACE
Detailhandel in farmaceutische producten
Groothandel in elektrische huishoudelijke apparaten en audio- en videoapparatuur
Verhuur en lease van televisietoestellen en andere audio- en videoapparatuur
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten